KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Current Assets (2017 - 2025)

Historic Current Assets for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $828.9 million.

  • Guardant Health's Current Assets fell 3243.05% to $828.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $828.9 million, marking a year-over-year decrease of 3243.05%. This contributed to the annual value of $1.1 billion for FY2024, which is 2167.55% down from last year.
  • Guardant Health's Current Assets amounted to $828.9 million in Q3 2025, which was down 3243.05% from $883.4 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Current Assets peaked at $2.0 billion during Q1 2021, and registered a low of $828.9 million during Q3 2025.
  • In the last 5 years, Guardant Health's Current Assets had a median value of $1.2 billion in 2022 and averaged $1.3 billion.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 23471.7% in 2021, then crashed by 4524.07% in 2022.
  • Guardant Health's Current Assets (Quarter) stood at $1.1 billion in 2021, then grew by 6.95% to $1.2 billion in 2022, then rose by 13.05% to $1.3 billion in 2023, then decreased by 21.68% to $1.1 billion in 2024, then dropped by 21.44% to $828.9 million in 2025.
  • Its Current Assets was $828.9 million in Q3 2025, compared to $883.4 million in Q2 2025 and $927.0 million in Q1 2025.